← LeaderboardsInvestigatorsiAttributed = a PI's even-split share of each grant — a $1M grant with 2 PIs counts $500K each.
Orlance, Inc.
Seattle, WA
$13,895,366
Total funding
9
Grants
Funding over time
peak $2.8M · FY2018–25$5M$3.8M$2.5M$1.3M$0
'18
'19
'20
'21
'22
'23
'24
'25
Funding mix
By agency
NIH$13,895,366 · 9
By mechanism
R44$11,996,753 · 5
R43$1,598,613 · 3
R41$300,000 · 1
Investigators at Orlance, Inc.
InvestigatorsiAttributed = a PI's even-split share of each grant — a $1M grant with 2 PIs counts $500K each.
Exposure= the full size of every grant they're on ($1M each).
Rising Stars
First grant in the last 5 yrs
Emerging Leaders
6–10 yrs in
All-Time
Most funded here, all years
Largest grants
DNA prime / rVSV boost Multi-Antigen Universal Influenza Vaccine$1,000,000
R44 · FY2021 · AI
Universal Influenza A/B Vaccine$1,000,000
R44 · FY2022 · AI
DNA prime / rVSV boost Multi-Antigen Universal Influenza Vaccine$1,000,000
R44 · FY2019 · AI
DNA prime / rVSV boost Multi-Antigen Universal Influenza Vaccine$1,000,000
R44 · FY2020 · AI
Universal Influenza A/B Vaccine$1,000,000
R44 · FY2024 · AI
Universal Influenza A/B Vaccine$998,889
R44 · FY2023 · AI
Clinic-Ready MACH-1 Gene Gun for delivery of a universal influenza DNA vaccine$996,500
R44 · FY2023 · AI
Clinic-Ready MACH-1 Gene Gun for delivery of a universal influenza DNA vaccine$990,275
R44 · FY2024 · AI
Clinic-Ready MACH-1 Gene Gun for delivery of a universal influenza DNA vaccine$977,255
R44 · FY2025 · AI
Development of a rapid response nucleic acid vaccine strategy for coronavirus epidemics$955,395
R44 · FY2021 · AI
Development of a rapid response nucleic acid vaccine strategy for coronavirusepidemics$908,934
R44 · FY2020 · AI
Optimization of an innate immune stimulating adjuvant for an HIV DNA vaccine$569,505
R44 · FY2019 · AI
Therapeutic nucleic acid vaccine for chronic hepatitis B in HIV/HBV co-infected individuals$300,000
R41 · FY2025 · AI
Universal Influenza A/B Vaccine$300,000
R44 · FY2020 · AI
Gene Gun-delivered RNA vaccines.$300,000
R43 · FY2024 · AI
Gene Gun-delivered RNA vaccines.$300,000
R43 · FY2025 · AI
Enhanced Seasonal Influenza Vaccine Targeting Variable and Conserved Antigens$300,000
R44 · FY2024 · AI
Design and Optimization of Clinical Gene Gun for Delivery of Nucleic Acid Vaccines$300,000
R43 · FY2018 · AI
Design and Optimization of Clinical Gene Gun for Delivery of Nucleic Acid Vaccines$298,613
R43 · FY2019 · AI
Next Generation Gene-Gun Delivered DNA and RNA Immunotherapeutic Vaccines for Melanoma.$200,000
R43 · FY2024 · CA